Stephan Stilgenbauer
0000-0002-6830-9296
Publication & Citation Trends
Publications
0 total
Censoring imbalances in randomized first-line trials of chronic lymphocytic leukemia.
Cited by 0
Semantic Scholar
Corrigendum to "U-RT1 - A new model for Richter transformation" [Neoplasia Volume 23, Issue 1, January 2021, Pages 140-148].
Cited by 0
Semantic Scholar
Short and complex—Telomeres and genomes in CLL
Cited by 0
Semantic Scholar
Venetoclax combinations in untreated CLL: 5-year results and patient-reported outcome analysis of the CLL13/GAIA trial
Cited by 0
Semantic Scholar
Results of brexucabtagene-autoleucel for patients with relapsed/refractory Mantle Cell Lymphoma in the routine setting in Germany and Switzerland.
Cited by 0
Semantic Scholar
Fitness beyond age: Multidisciplinary expert opinion on redefining fitness for targeted therapies in chronic lymphocytic leukemia
Cited by 0
Semantic Scholar
The spectrum of immunoglobulin heavy chain enhancer hijacking in chronic lymphocytic leukemia
Cited by 0
Semantic Scholar
First-line treatment for CLL in the era of targeted therapy
Cited by 2
Semantic Scholar
Research Topics
Chronic Lymphocytic Leukemia Research
(924)
Lymphoma Diagnosis and Treatment
(545)
Immunodeficiency and Autoimmune Disorders
(304)
Acute Lymphoblastic Leukemia research
(128)
Chronic Myeloid Leukemia Treatments
(90)
Affiliations
Leibniz University Hannover
The University of Sydney
Memorial Sloan Kettering Cancer Center
Karolinska University Hospital
Centre for Human Genetics